1-3 of 3
L. Rigacci
Close
Sort by
Journal Articles

Lack of Correlation between CD 52 Expression and Treatment Outcome in PTCL Patients Treated with CHOP Chemotherapy Plus Campath-1h (CHOP-C) as First Line Treatment.

Andrea Gallamini, C. Campidelli, F. Zaja, A. Billio, L. Gargantini, A. Manna, V. Secondo, A. Levis, L. Rigacci, P. Mazza, E. Iannitto, A. Pinto, A. Tucci, C. Patti, V. Zoli, P. Torchio, S. Ascani, S. Pileri
Journal: Blood
Blood (2006) 108 (11): 4732.
https://doi.org/10.1182/blood.V108.11.4732.4732
Published: 2006
Journal Articles

Advanced Stage Hodgkin Lymphoma: The Predictive Value on Treatment Outcome of Early FDG-PET Scan Is Independent of and Superior to IPS Score.

A. Gallamini, M. Hutchings, L. Rigacci, L. Specht, F. Merli, F. D’Amore, L. Nassi, M. Hansen, U. Vitolo, P. Kamper, L. Trentin, C. Stelitano, F. Di Raimondo, R. Sancetta, S. Luminari, S. Viviani, E. Iannitto, A. Levis
Journal: Blood
Blood (2006) 108 (11): 4592.
https://doi.org/10.1182/blood.V108.11.4592.4592
Published: 2006
Journal Articles

V H and V L Genes in Hairy Cell Leukemia Reveal a Dynamic On-Going Modification of the Surface B-Cell Receptor.

Francesco Forconi, MD, DM, PhD, T. Amato, D. Raspadori, BSci, S. S. Sahota, PhD, M. A. Dell’Aversano, M. Tassi, D. Rossi, MD, M. Bocchia, MD, M. Lenoci, MD, L. Rigacci, MD, F. Zaja, MD, G. Gaidano, MD, PhD, L. Leoncini, MD, Francesco Lauria, MD
Journal: Blood
Blood (2005) 106 (11): 287.
https://doi.org/10.1182/blood.V106.11.287.287
Published: 2005